Agent5Seven topics. One clear view.
Agent5

The latest AI news at a glance: seven topics, and a short, plain-English read on the stories. Free, no account.

Product
HomeHow it worksFAQAboutHow we fact-checkBlog
News
All newsModels & ReleasesFunding & DealsBenchmarksAgents & ProductsHardware & ComputePolicy & DramaRobotics
More
AdvertisePressPrivacyTerms
© 2026 Agent5
Agent5
Blog
Agent5
Blog
  1. Home›
  2. News›
  3. Funding & Deals›
  4. Anthropic files for IPO under ticker ANT
Models & Releases29Funding & Deals14Benchmarks14Agents & Products57Hardware & Compute14Policy & Drama31Robotics11
Funding & Deals

Anthropic files for IPO under ticker ANT

TechCrunch: Anthropic officially files for its public debut

Anthropic has officially filed for an IPO, revealing soaring revenue, mounting losses, major enterprise adoption, and an unusual governance structure designed to preserve founder control and its AI safety mission.

What happened

Anthropic, an AI company, officially filed paperwork with the Securities and Exchange Commission for an initial public offering on the Nasdaq under the ticker symbol ANT. The company reported $16.3 billion in revenue for the first half of 2026, up from $1.2 billion in the same period the previous year, though it posted an operating loss of $693 million. Seven co-founders will maintain collective control of 50.1% of shareholder voting power through a special governance structure designed to preserve the company's AI safety mission.

What each outlet adds
  • TechCrunch ↗: The governance structure is controversial because public shareholders will have little practical control over a company that acknowledges its technology poses catastrophic or existential risks to humanity.
  • SiliconANGLE ↗: The IPO could potentially raise as much as $100 billion, which would surpass the record set by a rival space exploration company's offering earlier in the year, and would make Anthropic the first pure-play AI company to publicly file for an IPO in the US.
  • Wired AI ↗: The filing includes extensive discussion of AI safety concerns, with the company describing potential existential threats to humanity.
  • Crunchbase News ↗: The S-1 filing is 335 pages long and includes an unusually extensive 93-page risk disclosure section covering both routine concerns and specialized risks such as the potential for future AI models to assist in developing dangerous weapons.
Why it matters

This filing marks one of the most closely watched public debuts in recent U.S. history and could be the largest IPO ever. The company's unusual governance structure that preserves founder control while acknowledging existential risks from its technology raises questions about public shareholder influence over a major AI developer.

Get smart on it

Anthropic, an AI company, has filed to become a publicly traded company under the ticker "ANT," marking one of the most closely watched public debuts in recent U.S. history. The company recorded $16.3 billion in revenue for the first half of 2026, a significant increase from $1.2 billion in the same period the previous year, though it reported an operating loss of $693 million. Seven co-founders will maintain control of the company through a special governance structure that gives them collective control of 50.1% of shareholder voting power, a move the company says is designed to preserve its AI safety mission. This governance structure is controversial because it means public shareholders will have little practical control over a company that acknowledges its technology poses "catastrophic or existential risks to humanity."

Relevant courses

Want to go deeper than the news? Explore live, cohort-based AI courses taught by practitioners.

Browse AI courses on Maven →
Sources
TechCrunch ↗
Also reported byCrunchbase News ↗SiliconANGLE ↗Wired AI ↗
The biggest AI stories, once a day

One short email a day with the stories that matter. Free. Unsubscribe with one click.

Related news
Funding & DealsOpen story →

OpenAI working on new $30B raise at $1.25T valuation ahead of IPO

Should OpenAI command an over $1 trillion valuation with this round, it would break records as the most highly valued private company ever.

Also reported by SiliconANGLE and The Decoder

Funding & DealsOpen story →

Anthropic’s IPO filing lays out a plan to ‘revolutionize every area of human endeavor’ with AI

Anthropic has filed its S-1 prospectus with the Securities and Exchange Commission, preparing the company behind Claude to beat OpenAI to the punch with an IPO. In a filing with the SEC, Anthropic said it plans to list on the Nasdaq exchange under the ticker symbol "ANT." The AI company confidentially filed with the SEC earlier this year in June, but the public document reveals more details, as well as the company's plans for the future in its own words, as well as potential r

Also reported by Wired AI

Funding & DealsOpen story →

Bedrock Robotics nears $1B in total funding as demand for autonomous heavy equipment surges

Bedrock Robotics automates large excavators to improve construction site economics. | Credit: Bedrock Robotics San Francisco-based Bedrock Robotics has raised $600 million in Series C funding, co-led by CapitalG and Emergence Capital, at a $4.1 billion valuation. The round brings its total funding to nearly $1 billion as it scales fully autonomous heavy equipment to address nationwide construction labor shortages. The round included new investors US Innovative Technology Fund (USIT), Bessemer Ve

Funding & DealsOpen story →

Five weird details from Anthropic’s IPO filing

Anthropic has finally filed its S-1 prospectus with the SEC, a document designed to give investors a look under the hood of its business, from how much its executives are making and plans for spending its IPO billions to the risks that could derail its ambitions. At more than 300 pages, there's a lot to unpack, and some of the disclosures have not previously been reported. Here are some of the biggest things that jumped out to us from our first pass: It pays to be an Amodei Sib

Funding & DealsOpen story →

DeepSeek reportedly raises $15B days after US restrictions

DeepSeek has reportedly raised $15 billion in one of China's largest funding rounds, just days after the US ordered federal agencies to remove its technology over national security concerns.

Funding & DealsOpen story →

OpenAI acquires Orchestra Bio to build AI agents that speed up drug development

OpenAI is acquiring startup Orchestra Bio and plans to merge it with its life sciences AI platform Rosalind. The goal is to build AI agents that help pharma teams coordinate drug development, from tracking trials to spotting problems. Developing a new drug in the US takes ten to 15 years on average. OpenAI already works with Novo Nordisk and Moderna on AI-driven pharma research. The article OpenAI acquires Orchestra Bio to build AI agents that speed up drug development appeared first on